Outcome/Subgroup | No of trials | No of participants | Risk Ratio (RR) | 95% Confidence interval (CI) | P value | Random effect; I2 statistic (%) | GRADE quality | |
---|---|---|---|---|---|---|---|---|
Reduction of menstrual blood loss of less than 80 ml | ||||||||
Frequency of drug administration | Twice a day (bd) | 4 | 663 | 4.90 | 2.59, 9.25 | P < 0.001 | 84 | Low |
Once a day (qd) | 2 | 223 | 3.35 | 1.28, 8.78 | P = 0.010 | 59 | Low | |
Uterine volume | < 500 cm3 | 2 | 311 | 8.75 | 4.97, 15.42 | P < 0.001 | 0 | Moderate |
> 500 cm3 | 3 | 558 | 3.66 | 1.96, 6.83 | P < 0.001 | 84 | Very low | |
Fibroid volume | < 50 cm3 | 2 | 252 | 8.77 | 4.98, 15.45 | P < 0.001 | 0 | Moderate |
> 50 cm3 | 3 | 632 | 3.85 | 2.09, 7.09 | P < 0.001 | 84 | Very low | |
Reduction of more than 50% menstrual blood loss | ||||||||
Frequency of drug administration | Twice a day (bd) | 4 | 663 | 5.00 | 2.74, 9.13 | P < 0.001 | 82 | Low |
Once a day (qd) | 2 | 221 | 2.47 | 1.87, 3.26 | P < 0.001 | 0 | Moderate | |
Uterine volume | < 500 cm3 | 2 | 311 | 8.75 | 4.97, 15.42 | P < 0.001 | 0 | Moderate |
> 500 cm3 | 3 | 558 | 3.75 | 2.06, 6.82 | P < 0.001 | 82 | Very low | |
Fibroid volume | < 50 cm3 | 2 | 252 | 4.66 | 0.92, 21.71 | P = 0.060 | 92 | Very low |
> 50 cm3 | 3 | 632 | 3.92 | 2.19, 7.03 | P < 0.001 | 82 | Very low |